- AU$272.31m
- AU$1.20bn
- AU$1.37bn
Brief: Healius To Sell Agilex Biolabs To Novotech
Australia's Healius rises on sale of unit Agilex Biolabs to Novotech Health
Brief: Healius Requests Trading Halt
Brief: Healius Expects To Achieve T27 Target Of Mid-To-High Single-Digit EBIT Margins By Dec 2028
Australia's Proteomics International soars on distribution deal with Healius
Brief: Healius Expects FY 2026 Group Underlying EBIT Of A$30 Million-A$35 Million
Australia's Healius at record low on inadequate funding, budget pressure woes
Australia's Healius drops on bigger-than-expected half-year loss
Brief: Healius Wins Contract For Supply Of Services To ADF
Australia's October Medicare growth muted; Jefferies holds view on healthcare providers
Brief: Healius Ltd Announces Appointment Of Andrew Thomson As CFO
Australia's Healius slips to nearly 27-year low on widening FY loss
Brief: Healius Continues To Expect To Achieve High Single Digit EBIT Margins By June 2027
Brief: Healius Declares Fully Franked Special Dividend Of 41.3 AU Cents Per Share
Australia's Healius hits near 6-month high on special dividend
Brief: Healius Completes Sale Of Lumus Imaging
Australian healthcare sector growth to be driven by bulk billing and incentives, says Jefferies
Australia's Healius aims high with EBIT margin target, outpacing Citi and Jefferies
Australia's Healius shares erase losses for year after strong trading update